Back to top
more

Becton, Dickinson and Company (BDX)

(Real Time Quote from BATS)

$234.45 USD

234.45
645,413

-1.89 (-0.80%)

Updated Sep 5, 2024 01:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Trina Mukherjee headshot

4 Lucrative MedTech Stocks to Bet On in 2021 Amid Pandemic

by Trina Mukherjee

Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

BD (BDX) Receives FDA EUA for Combination Rapid Antigen Test

by Zacks Equity Research

BD (BDX) gets FDA EUA for new rapid, antigen test, which can distinguish between COVID-19, influenza A and influenza B in a single test.

The Zacks Analyst Blog Highlights: NVIDIA, Accenture, Goldman Sachs, Becton, Dickinson and Co and Southern Copper

by Zacks Equity Research

The Zacks Analyst Blog Highlights: NVIDIA, Accenture, Goldman Sachs, Becton, Dickinson and Co and Southern Copper

Sheraz Mian headshot

Top Research Reports for NVIDIA, Accenture & Goldman Sachs

by Sheraz Mian

Today's Research Daily features new research reports on 12 major stocks, including NVIDIA (NVDA), Accenture (ACN), and Goldman Sachs (GS).

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

BD (BDX), ImageMover Partner for Rapid Antigen Test Reporting

by Zacks Equity Research

BD (BDX) collaborates with ImageMover to streamline rapid antigen testing results performed on the BD Veritor Plus System.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

by Trina Mukherjee

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

BD (BDX) Acquires GSL Solutions for Medication Management

by Zacks Equity Research

This acquisition should improve BD's (BDX) advanced medication management capabilities to further cater to the needs of retail pharmacies including those in outpatient settings.

Becton Dickinson (BDX) Down 3.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BD (BDX), Scanwell Health Collaborate on At-Home Coronavirus Test

by Zacks Equity Research

BD (BDX) plans to develop a lateral flow antigen test and pair it with the Scanwell Health mobile app via the latest partnership.

Sheraz Mian headshot

Top Stock Reports for Disney, Adobe & NextEra

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Adobe (ADBE), and NextEra Energy (NEE).

The Zacks Analyst Blog Highlights: Align Technology, Henry Schein, McKesson Corp and Becton, Dickinson and Co

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Align Technology, Henry Schein, McKesson Corp and Becton, Dickinson and Co

4 Dental Stocks to Watch on Likely Industry Turnaround

by Zacks Equity Research

The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

BD (BDX) Gets EUA, CE Mark for New Molecular Diagnostic Test

by Zacks Equity Research

BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.

All You Need to Know About Becton Dickinson (BDX) Rating Upgrade to Buy

by Zacks Equity Research

Becton Dickinson (BDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Align (ALGN) Extends Invisalign G8 Availability Worldwide

by Zacks Equity Research

Align's (ALGN) latest evolution in biomechanics is set to improve treatment predictability for frequently treated case types.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q1

by Zacks Equity Research

Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal first quarter.

Becton Dickinson (BDX) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Becton Dickinson (BDX) delivered earnings and revenue surprises of 44.90% and 0.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in Pharmaceutical segment.

What's in Store for Meridian Bioscience's (VIVO) Q1 Earnings?

by Zacks Equity Research

Meridian Bioscience's (VIVO) fiscal first-quarter results are likely to reflect strong performance by Life Science business line.

AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.

Baxter (BAX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Baxter's (BAX) fourth-quarter performance is likely to reflect growth in its Acute Therapies business.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

by Urmimala Biswas

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Q1 Release

by Zacks Equity Research

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.